Read more news
Susan Lowther
Chief Financial Officer
Susan Lowther joined Lab21 in July 2010 bringing with her a wealth of experience, gained over 20 years in the pharmaceutical, biotech and healthcare industries. She has extensive financial management expertise, gained from working with start up companies to global PLCs, covering both public and private financing, including venture capital financing and IPOs.
Susan also has extensive experience of M&A activity, including acquisition and divestment. Susan has held senior management positions at BioWisdom, RiboTargets, Lonza Biologics, Celltech and Monsanto.